Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00341835 · ClinicalTrials.gov registry record

Genetic Epidemiology of Lung Cancer

A clinical trial, sponsored by National Human Genome Research Institute (NHGRI).

Completed
Registry status
6,356
Enrollment target

NCT00341835 is a clinical trial that has completed, run by National Human Genome Research Institute (NHGRI). The registered enrollment target is 6,356 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00341835 has completed, sponsored by National Human Genome Research Institute (NHGRI).

COMPLETED
Registry status
6,356 participants
Enrollment target

Study Summary

This study will search for genes that greatly increase the risk of developing lung cancer in conjunction with cigarette smoking or other environmental agents, or both. Lung cancer is the second most common cancer diagnosed among men and women and the leading cause of cancer death in the United States. It has been frequently given as an example of cancer determined only by the environment, certain occupations, and dietary habits. Yet researchers have long had a hypothesis that people vary in their risk of becoming affected when exposed to these factors. Also, some evidence has shown that lung cancer in families may be due to the combined effects of inheritance of a major gene and cigarette smoking. Individuals who have a confirmed diagnosis of lung cancer or a family history of lung cancer may be eligible to enroll their families in the study. Family members will be asked to do one or more of the following: * Complete a questionnaire about personal medical history, lifestyle, and diet. * Have blood drawn from a vein in the arm. * If a family member has had a biopsy or is scheduled for one, give permission to obtain medical records and a portion of the stored tissue. * If any relatives have died of cancer, sign a release form to allow researchers to get copies of medical and pathology records, and tissue samples from surgery. If the family members agree, they may be recontacted to answer questions about their health and those of their family, during an annual telephone conversation. Follow-up questionnaires may be sent to participants, to determine if any new cancers have developed in the family. In the event of a new cancer, the classification of the family may change from the low-risk to intermediate risk-level and from the intermediate-risk to high-risk level. Follow-up will continue, to get information about tumors and death. Also, a newsletter for lung cancer families will occasionally be distributed to participants. In the future, the Internet will also prov

Trial Details

FieldValue
Enrollment Target 6,356 participants
Start Date 2003-08-26
Est. Completion 2020-04-17

What the Registry Record Tells You About NCT00341835

The ClinicalTrials.gov registry entry for NCT00341835 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 6,356 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Human Genome Research Institute (NHGRI), which has 185 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 0 interventions.

NCT00341835 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT00341835 about?

NCT00341835 is a clinical study titled "Genetic Epidemiology of Lung Cancer". This study will search for genes that greatly increase the risk of developing lung cancer in conjunction with cigarette smoking or other environmental agents, or both. Lung cancer is the second most common cancer diagnosed among men and women and the leading cause of cancer death in the United State...

What is the current status of trial NCT00341835?

This trial is currently completed. The enrollment target is 6,356 participants. The study started on 2003-08-26. Estimated completion is 2020-04-17.

Who is sponsoring clinical trial NCT00341835?

This trial is sponsored by National Human Genome Research Institute (NHGRI), which has 185 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.